BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3604257)

  • 1. N-hydroxy-N-arylacetamides. III: Mechanism of haemoglobin oxidation by N-hydroxy-4-chloroacetanilide in erythrocytes in vitro.
    Lenk W; Sterzl H
    Xenobiotica; 1987 Apr; 17(4):499-512. PubMed ID: 3604257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of 4-aminobiphenyl in rat. II. Reaction of N-hydroxy-4-aminobiphenyl with rat blood in vitro.
    Heilmair R; Karreth S; Lenk W
    Xenobiotica; 1991 Jun; 21(6):805-15. PubMed ID: 1949910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-hydroxy-N-arylacetamides. II: Molecular aspects of ferrihaemoglobin formation by N-hydroxy-N-arylacetamides and arylhydroxylamines in the rat.
    Lenk W; Sterzl H
    Xenobiotica; 1986 Aug; 16(8):703-16. PubMed ID: 3765653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-hydroxy-N-arylacetamides--IV. Differences in the mechanism of haemoglobin oxidation in vitro between N-hydroxy-N-arylacetamides and arylhydroxylamines.
    Heilmair R; Lenk W; Sterzl H
    Biochem Pharmacol; 1987 Sep; 36(18):2963-72. PubMed ID: 3632721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of 4-aminobiphenyl in rat. IV. Ferrihaemoglobin formation by 4-aminobiphenyl metabolites.
    Karreth S; Lenk W
    Xenobiotica; 1991 Jul; 21(7):971-7. PubMed ID: 1776272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-hydroxy-N-arylacetamides. V. Differences in the mechanism of haemoglobin oxidation in vitro by N-hydroxy-4-chloroacetanilide and N-hydroxy-4-chloroaniline.
    Lenk W; Riedl M
    Xenobiotica; 1989 Apr; 19(4):453-75. PubMed ID: 2546327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of 4-aminobiphenyl in rat. I. Reaction of N-hydroxy-4-aminobiphenyl with rat blood in vivo.
    Karreth S; Lenk W
    Xenobiotica; 1991 Mar; 21(3):417-28. PubMed ID: 1862663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxidase activity of oxyhaemoglobin in vitro.
    Lenk W; Sterzl H
    Xenobiotica; 1984 Jul; 14(7):581-8. PubMed ID: 6506772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of N-hydroxyphenacetin in vitro and in vivo.
    Fischbach T; Lenk W
    Xenobiotica; 1985 Nov; 15(11):915-27. PubMed ID: 4082632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Hydroxy-N-arylacetamides. I. Toxicity of certain polycyclic and monocyclic N-hydroxy-N-arylacetamides in rats.
    Fischbach T; Hertle H; Kiese M; Lenk W; Sterzl H; Meister P
    Arch Toxicol; 1984 Dec; 56(2):96-105. PubMed ID: 6532384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detoxication of N-oxygenated arylamines in erythrocytes. An overview.
    Eyer P
    Xenobiotica; 1988 Nov; 18(11):1327-33. PubMed ID: 3072780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free radical activation of N-hydroxy-2-acetylaminofluorene by methemoglobin and hydrogen peroxide.
    Walker RN; Floyd RA
    Cancer Biochem Biophys; 1979; 4(2):87-93. PubMed ID: 552909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferrihaemoglobin formation by amyl nitrite and sodium nitrite in different species in vivo and in vitro.
    Klimmek R; Krettek C; Werner HW
    Arch Toxicol; 1988; 62(2-3):152-60. PubMed ID: 2904249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on the interaction between hydroxylamine analogues and oxyhemoglobin in intact erythrocytes.
    Spooren AA; Evelo CT
    Blood Cells Mol Dis; 2000 Aug; 26(4):373-86. PubMed ID: 11042038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NADH/NADPH-methemoglobin reduction system or erythrocytes.
    Hultquist DE; Sannes LJ; Schafer DA
    Prog Clin Biol Res; 1981; 55():291-309. PubMed ID: 7027268
    [No Abstract]   [Full Text] [Related]  

  • 16. Peroxidative metabolism of a carcinogen, N-hydroxy-N-2-fluorenylacetamide, by rat uterus and mammary gland in vitro.
    Malejka-Giganti D; Ritter CL; Decker RW; Suilman JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6200-6. PubMed ID: 3779640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative toxicity of N-hydroxy-2-acetylaminofluorene in several strains of rats.
    Irving CC
    Cancer Res; 1975 Nov; 35(11 Pt 1):2959-61. PubMed ID: 1182689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mechanisms for toxic effects of hydroxylamines in human erythrocytes: involvement of free radicals and risk of potentiation.
    Evelo CT; Spooren AA; Bisschops RA; Baars LG; Neis JM
    Blood Cells Mol Dis; 1998 Sep; 24(3):280-95. PubMed ID: 10087986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrogen oxidation in ferrihaemoglobin formation.
    Kiese M
    Xenobiotica; 1971; 1(4):553-62. PubMed ID: 4152973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.